The innovative drug concept collectively declined. Lianhuan Pharmaceutical and Onlikang both fell to a standstill. Previously, Minovar fell to a standstill, Tianjin Pharmaceutical was close to a standstill, and Shu Taishen and Hualan shares fell by more than 11%, followed by Frontier Biology, Kangzhi Pharmaceutical, and Shuanglu Pharmaceutical.
智通財經·07/21/2026 02:09:06
語音播報
The innovative drug concept collectively declined. Lianhuan Pharmaceutical and Onlikang both fell to a standstill. Previously, Minovar fell to a standstill, Tianjin Pharmaceutical was close to a standstill, and Shu Taishen and Hualan shares fell by more than 11%, followed by Frontier Biology, Kangzhi Pharmaceutical, and Shuanglu Pharmaceutical.